Want to see IL:ALBA full AI Analyst Report?
Top Page
Albaad
(TASE:ALBA)
Select Model
Select Model
Rating:68Neutral
Price Target:
3,665.00
▲(14.60% Upside)
Action:Reiterated
Date:08/21/26
The score is driven primarily by improved financial performance (profit recovery and better returns), tempered by ongoing leverage and flat-to-down revenue. Technicals are constructive with price above major moving averages, but overbought signals (high RSI/Stoch) add near-term risk. Valuation is supportive due to a low P/E, though the lack of dividend reduces total-return cushioning.
Positive Factors
Profit recovery and margin expansion
Net income recovered from losses in 2021–2022 to 73.2M TTM, while TTM net margin reached about 4.2%. This indicates stronger operating economics and provides a better base to fund growth and absorb cost pressure.
Negative Factors
Flat-to-declining revenue
Stagnant or declining revenue suggests limited volume, pricing or market-share momentum. Without renewed top-line growth, Albaad may have less operating leverage and fewer opportunities to offset input costs or expand profit sustainably.
Read all positive and negative factors
Positive Factors
Negative Factors
Profit recovery and margin expansion
Net income recovered from losses in 2021–2022 to 73.2M TTM, while TTM net margin reached about 4.2%. This indicates stronger operating economics and provides a better base to fund growth and absorb cost pressure.
Read all positive factors
Albaad (ALBA) vs. iShares MSCI Israel ETF (EIS)
Market Cap
₪613.13M
Dividend Yield0%
Average Volume (3M)12.38K
Price to Earnings (P/E)8.4
Beta (1Y)0.64
Revenue Growth-1.02%
EPS Growth42.98%
CountryIL
Employees1,766
SectorGeneral
Sector StrengthN/A
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)3.93
Shares Outstanding18,647,507
10 Day Avg. Volume11,904
30 Day Avg. Volume12,385
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)1.42
Price to Sales (P/S)0.38
P/FCF Ratio11.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Albaad Business Overview & Revenue Model
Company Description
Albaad Massuot Yitzhak Ltd is a global producer and distributor of a wide variety of wet wipe products. Its extensive range includes personal hygiene items such as disinfecting and antibacterial hand wipes, as well as cosmetic wipes tailored for f...
How the Company Makes Money
Albaad makes money primarily by manufacturing and selling hygiene products—especially wipes—under two main models: (1) private-label/contract manufacturing, where it produces products that are sold under a retailer’s or third party’s brand, and (2...
Albaad Financial Statement Overview
Summary
Income Statement
71
Positive
Balance Sheet
55
Neutral
Cash Flow
63
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.73B | 1.76B | 1.72B | 1.71B | 1.45B | 1.49B |
| Gross Profit | 369.24M | 349.10M | 347.93M | 344.37M | 235.00M | 270.70M |
| EBITDA | 218.01M | 218.31M | 192.42M | 176.03M | 78.18M | 192.56M |
| Net Income | 73.25M | 69.69M | 44.88M | 30.23M | -35.12M | -20.34M |
Balance Sheet | ||||||
| Total Assets | 1.45B | 1.50B | 1.51B | 1.58B | 1.60B | 1.57B |
| Cash, Cash Equivalents and Short-Term Investments | 21.99M | 10.81M | 25.16M | 19.13M | 27.19M | 18.24M |
| Total Debt | 615.09M | 702.17M | 712.92M | 829.03M | 836.53M | 802.11M |
| Total Liabilities | 956.32M | 1.02B | 1.07B | 1.18B | 1.24B | 1.14B |
| Stockholders Equity | 483.92M | 474.19M | 426.68M | 394.08M | 346.83M | 430.25M |
Cash Flow | ||||||
| Free Cash Flow | 88.57M | 56.34M | 101.60M | 120.98M | -67.58M | -38.08M |
| Operating Cash Flow | 165.45M | 127.49M | 152.50M | 233.23M | 18.57M | 52.58M |
| Investing Cash Flow | -76.81M | -101.94M | -9.51M | -110.94M | -30.36M | -170.24M |
| Financing Cash Flow | -75.66M | -40.28M | -135.56M | -134.49M | 20.46M | 103.68M |
Albaad Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ₪736.44M | 15.30 | ― | 15.93% | 4.06% | -21.69% | |
68 Neutral | ₪613.13M | 8.37 | ― | 0.00% | -1.02% | 42.98% | |
67 Neutral | ₪313.80M | 25.72 | ― | 9.06% | -22.23% | -88.63% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
43 Neutral | ₪122.15M | 2.03 | ― | 32.90% | 6.09% | -13.79% |
* General Sector Average
IL:ALBA
Albaad
3,288.00
662.89
25.25%
IL:SANO1
Sano
37,000.00
3,216.55
9.52%
IL:GSFI
Gan Shmuel
2,090.00
-852.00
-28.96%
IL:WLFD
Willy Food
5,584.00
2,021.00
56.72%
IL:GLRS
Globrands
9,874.00
-39,138.26
-79.85%
IL:CRML
Carmel Corp
1,499.00
-422.00
-21.97%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.